TowerBrook Seeks $800m to Extend TriMedx Ownership

Investment firm TowerBrook Capital Partners is seeking around $800m for a single-asset continuation fund that would give the firm more capital and time to support portfolio company TriMedx Holdings, The Wall Street Journal reported.

The TowerBrook fund would be one of the latest such vehicles to be raised in a rapidly expanding secondary segment of private markets.

Health-care companies were more or less flat as traders sought out sectors better equipped to handle an era of rising inflation and slowing economic growth.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter

TowerBrook Capital Partners is a purpose-driven, transatlantic investment firm that works to grow and improve large and middle-market businesses by partnering with management teams and employees to build excellent companies that make a positive impact on society. Since inception in 2001, TowerBrook has raised a total of $18.7 billion and invested in more than 85 companies on both sides of the Atlantic.

TowerBrook operates as a single, unified team of experienced investment professionals focused on unlocking value in complex situations. The firm’s highly synergistic family of funds make control and non-control investments across the capital structure, providing capital and resources to transform the capabilities and prospects of its portfolio companies.

As a disciplined investor with a commitment to fundamental value, TowerBrook seeks to deliver superior, risk-adjusted returns to investors on a consistent and responsible basis.

TowerBrook is the first mainstream private equity firm to be certified as a B Corporation. B Corporation certification is administered by the non-profit B Lab organisation and is awarded to companies that demonstrate leadership in their commitment to environmental, social and governance (ESG) standards and responsible business practices.

Source: Morning Star

Can’t stop reading? Read more